Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gerresheimer AG (DE:GXI)
XETRA:GXI
Holding DE:GXI?
Track your performance easily
GXI Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€81.35 - €122.90
Previous Close€95.05
Volume28.69K
Average Volume (3M)98.15K
Market Cap
€3.28B
Enterprise Value€4.51B
Total Cash (Recent Filing)€121.67M
Total Debt (Recent Filing)€1.32B
Price to Earnings (P/E)28.5
Beta0.65
Next Earnings
Oct 10, 2024EPS Estimate
€1.22Last Dividend Ex-Date
Jun 06, 2024Dividend Yield1.27%
Share Statistics
EPS (TTM)3.33
Shares OutstandingN/A
10 Day Avg. Volume59,412
30 Day Avg. Volume98,153
Standard Deviation0.09
R-Squared0.10
Alpha0.00884
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€127.53Price Target Upside34.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Gerresheimer News
PremiumPre-Earnings
Is 0NTI a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
AcquisitionAcquisition could bring 10% EPS accretion in FY25, with the acquisition of Bormioli Pharma adding a complementary portfolio of products.
Market ConditionsA stronger second half of the year is expected due to better market conditions and increased capacity.
ProfitabilityProfitability uplift expected, on track to meet the EBITDA guide, which is seen as conservative at the full-year level.
Bears Say
EarningsGerresheimer reported organic growth of only 0.7%, which is below expectations.
ProfitabilityProfitability uplift is likely to be suppressed by destocking in the PPG segment.
Revenue Growth1H revenue growth of 1.2% suggests that 2H growth is unlikely to reach the upper half of the guided range.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
20.31% Mutual Funds
6.18% Other Institutional Investors
73.51% Public Companies and
Individual Investors
GXI FAQ
What was Gerresheimer AG’s price range in the past 12 months?
Gerresheimer AG lowest stock price was €81.35 and its highest was €122.90 in the past 12 months.
What is Gerresheimer AG’s market cap?
Currently, no data Available
When is Gerresheimer AG’s upcoming earnings report date?
Gerresheimer AG’s upcoming earnings report date is Oct 10, 2024 which is in 47 days.
How were Gerresheimer AG’s earnings last quarter?
Gerresheimer AG released its earnings results on Jul 11, 2024. The company reported €1.24 earnings per share for the quarter, beating the consensus estimate of €1.103 by €0.137.
Is Gerresheimer AG overvalued?
According to Wall Street analysts Gerresheimer AG’s price is currently Undervalued.
Does Gerresheimer AG pay dividends?
Gerresheimer AG pays a Annually dividend of €1.25 which represents an annual dividend yield of 1.27%. See more information on Gerresheimer AG dividends here
What is Gerresheimer AG’s EPS estimate?
Gerresheimer AG’s EPS estimate is €1.22.
How many shares outstanding does Gerresheimer AG have?
Gerresheimer AG has 34,540,000 shares outstanding.
What happened to Gerresheimer AG’s price movement after its last earnings report?
Gerresheimer AG reported an EPS of €1.24 in its last earnings report, beating expectations of €1.103. Following the earnings report the stock price went up 1.942%.
Which hedge fund is a major shareholder of Gerresheimer AG?
Currently, no hedge funds are holding shares in DE:GXI
---
Gerresheimer Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.20%
12-Months-Change
Fundamentals
Return on Equity
7.86%
Trailing 12-Months
Asset Growth
6.98%
Trailing 12-Months
Company Description
Gerresheimer AG
Gerresheimer AG provides specialty glass and plastic products to the pharmaceutical and healthcare industry. The firm operates in three segments: plastics and devices, primary packaging glass and advanced technologies. The plastics and devices segment sells products for drug administration, including insulin pens, inhalers, prefillable syringes, and plastic packaging for medications. The primary packaging glass segment produces glass packaging products for drugs and cosmetics, such as injection vials, cartridges, and jars. The advanced technologies segment develops and manufactures intelligent drug delivery systems. Gerresheimer generates the majority of its revenue in Europe, with sales in Germany contributing the largest proportion of any country.
---
GXI Stock 12 Month Forecast
Average Price Target
€127.53
▲(34.38% Upside)
Technical Analysis
Best Analysts Covering GXI
1 Year
1 Year Success Rate
20/33 ratings generated profit
1 Year Average Return
+4.46%
reiterated a buy rating last month
Copying Oliver Reinberg's trades and holding each position for 1 Year would result in 60.61% of your transactions generating a profit, with an average return of +4.46% per trade.
---